Abstract
Glycoprotein 96 (gp96), a member of the heat-shock protein family, can elicit priming of antigen-specfic cytotoxic T lymphocytes, when bound to antigenic viral or tumour peptides. We used direct peptide isolation from purified gp96 and microsequencing to show that a virus-specific peptide is bound to gp96 derived from liver tissues of patients with hepatitis B virus (HBV)-induced hepatocellular carcinoma. This virus-specific peptide has potential for engineering tumour vaccines against hepatocellular carcinoma and chronic HBV infection.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Neoplasm / metabolism*
-
Cancer Vaccines
-
Carcinoma, Hepatocellular / metabolism*
-
Carcinoma, Hepatocellular / virology
-
Heat-Shock Proteins / metabolism*
-
Hepatitis B / complications
-
Hepatitis B / metabolism*
-
Hepatitis B Core Antigens / metabolism*
-
Humans
-
Liver Neoplasms / metabolism*
-
Liver Neoplasms / virology
-
Peptide Fragments / metabolism
-
Protein Binding
Substances
-
Antigens, Neoplasm
-
Cancer Vaccines
-
Heat-Shock Proteins
-
Hepatitis B Core Antigens
-
Peptide Fragments
-
sarcoma glycoprotein gp96 rejection antigens